Peginterferon Alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment[1], [2] and [3] 1 2 3☆
Mitchell L. Shiffman, Adrian M. Di Bisceglie, Karen L. Lindsay, Chihiro Morishima, Elizabeth Cox Wright, Gregory T. Everson, Anna S. Lok, Timothy R.M. Morgan, Herbert L. Bonkovsky, William M. Lee
Abstract
Open-access reader